Published in Hepatitis Weekly, January 13th, 2003
G.L. Davis and colleagues combined "data from two large clinical trials of peginterferon and ribavirin ... and analyzed [them] to determine the optimal definition of an EVR which, if not achieved, was associated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly